Schedule 13G ownership disclosure
Carbylan Therapeutics, Inc.
Security class unavailable · CUSIP: 141384107
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.4130%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-16-005727
- Form type
- SC 13G
- Filer
- KalVista Pharmaceuticals, Inc.
- CIK
- CIK 1348911
- Filed
- Apr 11, 2016
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership